BREA, Calif., Aug. 24, 2020 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay. The new IgM antibody test ...

WASHINGTON -- U.S. regulators are moving ahead with a crackdown on scores of antibody tests for the coronavirus that have not yet been shown to work. The Food and Drug Administration on Thursday ...

The COVID-19 pandemic has spread all over the world, affecting millions of people. Some show symptoms of COVID-19. To know whether a person has COVID-19 or not, he or she must undergo rapid testing ...

Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test ...

Announcing a new article publication for Zoonoses journal. The COVID-19 pandemic, which was caused by SARS-CoV-2, has had a significant effect on global public health, economies, and societies ...

"Our new SARS-CoV-2 IgM assay provides information about an individual's immune status with a positive predictive value of 95.5% in a population with disease incidence as low as 3%," said Julie Sawyer ...